Softgel Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin/Animal-Based, Non-animal Based), By Application (Antacid and Anti-flatulent Preparations, Anti-anemic Preparations, Anti-inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplement, Vitamin and Dietary Supplement, Pregnancy), By Manufacturers (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organizations, Softgel Capsules) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Softgel Capsules Market Size

The global softgel capsules market size was valued at USD 8.78 billion in 2025 and is projected to grow from USD 9.32 billion in 2026 to USD 14.96 billion by 2034, registering a CAGR of 6.1% during the forecast period from 2026 to 2034. North America dominated the softgel capsules market with a market share of 38.2% in 2025.

Softgel capsules are orally administered in capsule dosage form and predominantly comprise gelatin, pullulan, HPMC, potato starch, pectin, and other ingredients. Softgel capsules carry liquid, semisolid, or solid medication that dissolves more rapidly in the gastric fluids than a hard gelatin capsule. These are commonly employed in formulating poorly soluble medicines to improve their absorption. The market is expanding for several key reasons, including the rising prevalence of chronic diseases like cardiovascular disease and the rising demand for better drug therapies.

According to the American College of Cardiology, more than 523 million people worldwide are affected by several cardiovascular problems. The increasing prevalence of chronic diseases would increase the demand for softgel capsules for patient treatment. Consequently, boosting the availability of novel softgel capsules in emerging economies through developing innovative products will drive market expansion during the forecast period.

Type Insights

The market is segmented into gelatin/animal-based and non-animal based. The gelatin-based softgel capsules dominate the market due to the high prevalence of several chronic diseases, such as infections and cardiovascular diseases. Furthermore, the growing acceptance of softgel capsules due to their numerous benefits, such as flavor masking, ease of swallowing, and longer shelf life, will drive the growth of this market. The high preference among nutraceutical and pharmaceutical manufacturers for gelatin-based empty capsules for various formulations due to their ease of use and non-reactive nature is expected to drive the growth of the market revenue.

Request Customizationto receive a tailored report.

Application Insights

The market is segmented into antacid and anti-flatulent preparations, anti-anemic preparations, anti-inflammatory drugs, antibiotic and antibacterial drugs, cough and cold preparations, health supplements, vitamin and dietary supplements, and pregnancy. The health and dietary category are the most dominant in the market because of the increased use of vitamins and minerals to strengthen one's immune system. Additionally, increasing people's awareness of the importance of maintaining a healthy lifestyle will increase the demand for nutritional supplements such as omega3 and others.

Manufacturers Insights

The market is segmented into pharmaceutical companies, nutraceutical companies, cosmeceutical companies, contract manufacturing organizations, and softgel capsules. The pharmaceutical business segment is anticipated to expand in a lucrative manner due to the availability of softgel capsules for treating various disorders. The fact that a significant number of pharmaceutical companies in the market are working to develop novel drugs to improve patient outcomes will also contribute to the growth of the softgel capsule market.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant shareholder in the global softgel capsules industry due to the rising desire of critical companies to debut products in developed countries. The most significant players strive to receive approvals from the Food and Drug Administration (FDA) of the United States and other regulatory organizations to expand their client bases in other locations. Europe is the second-dominant region because various European countries have increased their funding for research and development of soft gelatin capsules.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Softgel Capsules Market Trends

It is anticipated that the market in Asia-Pacific will grow at the highest CAGR due to a larger patient pool that is afflicted with multiple chronic illnesses. In addition, the geographic expansion of key companies into the new economies of the Asia-Pacific region will further increase its growth rate for the entirety of the analytical time frame. LAMEA has tremendous growth potential and is anticipated to become a lucrative market. The rising prevalence of chronic diseases like cardiovascular disease (CVD) and rising public awareness of the consumption of various dietary and health supplements are a few factors that are likely to support the market's growth in these regions.

List of Key and Emerging Players in Softgel Capsules Market